Form 4: Heron Therapeutics, Inc. /De/ Executive Reports Stock Transa
Insider Transaction (Form 4)
William P Forbes, EVP, Chief Development Officer of Heron Therapeutics, Inc. /De/, reported multiple transactions in common stock on July 30, 2026.
Summary
- Option exercise/conversion: acquired 11,769 Common Stock on July 30, 2026; holds 236,153 after (Direct).
- Tax/exercise-price withholding: disposed of 3,348 Common Stock at $0.50 ($1,674) on July 30, 2026; holds 232,805 after (Direct).
- Option exercise/conversion: acquired 11,694 Common Stock on July 31, 2026; holds 244,499 after (Direct).
- Tax/exercise-price withholding: disposed of 3,326 Common Stock at $0.50 ($1,663) on July 31, 2026; holds 241,173 after (Direct).
- Option exercise/conversion: disposed of 11,769 Restricted Stock Units on July 30, 2026; holds 164,776 after (Direct).
- Option exercise/conversion: disposed of 11,694 Restricted Stock Units on July 31, 2026; holds 116,944 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
William P Forbes — Officer (EVP, Chief Development Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-30 | Option exercise/conversion | Common Stock | 11,769 | — | — | 236,153 |
| 2026-07-30 | Tax/exercise-price withholding | Common Stock | 3,348 | $1 | $1.7K | 232,805 |
| 2026-07-31 | Option exercise/conversion | Common Stock | 11,694 | — | — | 244,499 |
| 2026-07-31 | Tax/exercise-price withholding | Common Stock | 3,326 | $1 | $1.7K | 241,173 |
| 2026-07-30 | Option exercise/conversion | Restricted Stock Units | 11,769 | — | — | 164,776 |
| 2026-07-31 | Option exercise/conversion | Restricted Stock Units | 11,694 | — | — | 116,944 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-30 | Option exercise/conversion (11,769 shares) |
| 2026-07-30 | Tax/exercise-price withholding (3,348 shares) |
| 2026-07-31 | Option exercise/conversion (11,694 shares) |
| 2026-07-31 | Tax/exercise-price withholding (3,326 shares) |
| 2026-07-30 | Option exercise/conversion (11,769 shares) |
| 2026-07-31 | Option exercise/conversion (11,694 shares) |
Keywords
insider transaction, Form 4, HRTX, HERON THERAPEUTICS, INC. /DE/, neutral, William P Forbes
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.